UPC
Universe Pharmaceuticals Inc
NASDAQ: UPC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.21
-0.60% today
Updated 2026-05-01
Market cap
$1.74M
P/E ratio
—
P/S ratio
0.10x
EPS (TTM)
$-8.06
Dividend yield
—
52W range
$2 – $11
Volume
0.0M
Universe Pharmaceuticals Inc (UPC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-20.60%
Operating margin
-6.77%
ROE
-7.23%
ROA
-2.66%
Debt/equity
0.16x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $28.51M | $7.60M | 47.03% | 33.87% | 26.66% |
| 2019 | $33.23M | $7.55M | 40.35% | 29.35% | 22.73% |
| 2020 | $30.70M | $7.56M | 45.90% | 33.39% | 24.62% |
| 2021 | $47.98M | $11.32M | 52.78% | 28.32% | 23.59% |
| 2022 | $40.14M | $-8.74M | 54.53% | -17.49% | -21.76% |
| 2023 | $32.31M | $-6.16M | 31.93% | -10.92% | -19.08% |
| 2024 | $23.02M | $-8.73M | 26.37% | -34.83% | -37.90% |
| 2025 | $17.86M | $-3.67M | 35.28% | -16.33% | -20.56% |